Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110864375 | 11086437 | 5 | F | 20150403 | 20160706 | 20150504 | 20160713 | EXP | IT-009507513-1504ITA023915 | MERCK | 68.00 | YR | F | Y | 75.00000 | KG | 20160713 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110864375 | 11086437 | 1 | PS | REBETOL | RIBAVIRIN | 1 | UNK | 20903 | CAPSULE | ||||||||||
| 110864375 | 11086437 | 2 | SS | REBETOL | RIBAVIRIN | 1 | Oral | 1000 MG, DAILY | 20903 | CAPSULE | QD | ||||||||
| 110864375 | 11086437 | 3 | SS | PEGINTERFERON ALFA-2B | PEGINTERFERON ALFA-2B | 1 | UNK | Y | 0 | SUBCUTANEOUS INJECTION | |||||||||
| 110864375 | 11086437 | 4 | SS | RITONAVIR. | RITONAVIR | 1 | Oral | 100 MG, DAILY | 14-006453 | 0 | 100 | MG | QD | ||||||
| 110864375 | 11086437 | 5 | SS | OMBITASVIR | OMBITASVIR | 1 | UNK | 0 | |||||||||||
| 110864375 | 11086437 | 6 | SS | ABT-450 | PARITAPREVIR | 1 | UNK | 0 | |||||||||||
| 110864375 | 11086437 | 7 | SS | DASABUVIR | DASABUVIR | 1 | UNK | 0 | |||||||||||
| 110864375 | 11086437 | 8 | C | KANRENOL | CANRENOATE POTASSIUM | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 110864375 | 11086437 | 9 | C | LASIX | FUROSEMIDE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 110864375 | 11086437 | 10 | C | NORMIX | RIFAXIMIN | 1 | Oral | UNK | 0 | ||||||||||
| 110864375 | 11086437 | 11 | C | PANTORC | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 110864375 | 11086437 | 12 | C | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 110864375 | 11086437 | 13 | C | KONAKION | PHYTONADIONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110864375 | 11086437 | 1 | Chronic hepatitis C |
| 110864375 | 11086437 | 3 | Chronic hepatitis C |
| 110864375 | 11086437 | 4 | Chronic hepatitis C |
| 110864375 | 11086437 | 5 | Chronic hepatitis C |
| 110864375 | 11086437 | 6 | Chronic hepatitis C |
| 110864375 | 11086437 | 7 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110864375 | 11086437 | HO |
| 110864375 | 11086437 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110864375 | 11086437 | Confusional state | |
| 110864375 | 11086437 | Disorientation | |
| 110864375 | 11086437 | Drug intolerance | |
| 110864375 | 11086437 | Hepatic encephalopathy | |
| 110864375 | 11086437 | Lethargy | |
| 110864375 | 11086437 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110864375 | 11086437 | 2 | 20150309 | 0 | ||
| 110864375 | 11086437 | 4 | 20150309 | 0 | ||
| 110864375 | 11086437 | 5 | 20150309 | 0 | ||
| 110864375 | 11086437 | 6 | 20150309 | 0 | ||
| 110864375 | 11086437 | 7 | 20150309 | 0 | ||
| 110864375 | 11086437 | 8 | 20141101 | 0 | ||
| 110864375 | 11086437 | 9 | 20141101 | 0 | ||
| 110864375 | 11086437 | 10 | 20141101 | 0 | ||
| 110864375 | 11086437 | 11 | 20141101 | 0 | ||
| 110864375 | 11086437 | 12 | 20141101 | 0 | ||
| 110864375 | 11086437 | 13 | 20141101 | 0 |